Deutsche Bank
CAI

Deutsche Bank’s Caris Life Sciences CAI Stock Holding History

Deutsche Bank’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$778K Buy
43,653
+5,363
+14% +$96K ﹤0.01% 2517
2026
Q1 		$685K Buy
38,290
+13,000
+51% +$284K ﹤0.01% 2410
2025
Q4 		$682K Hold
25,290
– – ﹤0.01% 2396
2025
Q3 		$765K Hold
25,290
– – ﹤0.01% 2317
2025
Q2 		$676K Buy
+25,290
New +$682K ﹤0.01% 2302

Other funds holding CAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Deutsche Bank's CAI Position: Q2 2026 in Review

Deutsche Bank increased its Caris Life Sciences (CAI) stake by 14% in Q2 2026, buying an estimated $96K and bringing the position to 43,653 shares worth $778K. The position accounts for ﹤0.01% of the portfolio, ranked #2517.

Deutsche Bank first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 96 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Deutsche Bank held 43,653 shares of Caris Life Sciences worth $778K as of Q2 2026.
  • Deutsche Bank bought 5,363 Caris Life Sciences shares in Q2 2026, an estimated $96K.
  • Caris Life Sciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2517 holding.
  • Deutsche Bank first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 96 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.